search
Multiply Labs
Trends
- 1Soon-Shiong's NantWorks backs biotech manufacturing startups Prolific Machines and Multiply Labs▼NantWorks' Soon-Shiong puts chips behind manufacturing disruptors in new rounds for Prolific Machines, Multiply Labs
Billionaire biotech entrepreneur Patrick Soon-Shiong's NantWorks has invested in new funding rounds for Prolific Machines and Multiply Labs, two startups aiming to disrupt biopharmaceutical manufacturing. Prolific Machines works on light-based cell culture control, while Multiply Labs develops robotics for drug production, and the investments signal growing interest in technology-driven manufacturing innovation.
- 2
Multiply Labs has raised $75 million to expand its robotics platform for pharmaceutical manufacturing, SiliconANGLE reports. The startup builds automated systems that handle drug production tasks, aiming to cut costs and speed up medicine manufacturing. The funding round is drawing attention as drugmakers look to automate production amid supply chain pressures.